Subscribe to our Newsletters !!
Drug quality is defined not only how a drug is man
Eppendorf is proud to announce the launch of its D
The Nobel Prize in Physiology or Medicine awarded
This year, the Hamburg based life sciences company
Alembic Pharmaceuticals Ltd., t
Since it’s an ingredient in so many foods, you h
Dear Readers, Welcome to the latest issue of Micr
US drugmaker Moderna Inc will supply its COVID-19 vaccine into the authorities of Taiwan and Colombia, the company said, providing five million and 10 million doses respectively.
Moderna’s COVID-19 vaccine isn’t yet approved for use in Taiwan or Colombia and the company’s statement said it will work with regulators to pursue necessary approvals prior to distribution.
Deliveries are expected to start in mid-2021, the company added.
Late in December Taiwan said it had agreed to purchase almost 20 million doses of COVID-19 vaccine, including 10 million in UK drugmaker AstraZeneca, with the rest coming from the COVAX global vaccine programme and an unnamed company.
Taiwan has not previously announced the Moderna deal and has kept details of its vaccine programs largely under wraps, citing commercial confidentiality.
“We will endeavour to push them to supply them as quickly as possible,” Chen said on Wednesday.
The government has moved to assure its people it is working hard to guarantee access to vaccines and is also developing vaccines domestically, though at a slower rate.
However, officials have also suggested that with the pandemic in check in Taiwan there isn’t the pressing need for vaccines that some other nations are facing. There are now just 73 active cases being treated in hospital.
Germany last week ducked an appeal by Taiwan for its aid to provide COVID-19 vaccines. Berlin had earlier asked the Asian technology powerhouse to ease a semiconductor supply crunch in the auto industry, possibly provoking China’s ire.
Vaccines supplies are tight worldwide in any case.
